Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.
Researchers from MIT have developed a 3D-printable tissue adhesive that demonstrates superior tissue adhesion, rapid sealing capabilities across various surgical scenarios and a unique blood-repelling ...
Biological tissues have a remarkable ability to organize and change shape, driven by forces generated by their own cells. One of the major challenges in bioengineering is harnessing this natural ...
Tissue expansion is a common technique used in reconstructive surgery. Surgeons slowly stretch nearby skin to grow extra ...
In the realm of biomedical sciences, the quest for accurate and efficient diagnostic tools is ever-evolving. One such promising innovation making waves is the photoacoustic (PA) technique. In the past ...
YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
YOKOHAMA, Japan, May 11, 2026--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. ("CTBE"), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results